| Literature DB >> 25414725 |
Efe Erdeş1, Tuğba Somay Doğan2, Ilhan Coşar3, Tarık Danışman3, Kadir Boğaç Kunt4, Tamay Seker5, Meral Yücel6, Can Ozen7.
Abstract
BACKGROUND: Scorpion venoms are rich bioactive peptide libraries that offer promising molecules that may lead to the discovery and development of new drugs. Leiurus abdullahbayrami produces one of the most potent venoms among Turkish scorpions that provokes severe symptoms in envenomated victims.Entities:
Keywords: Antimicrobial activity; Cytotoxicity; Electrophoresis; Leiurus abdullahbayrami; Microfluidic capillary; Peptide; Peptidomics; Scorpion venom; Toxin; Turkey; Venomics
Year: 2014 PMID: 25414725 PMCID: PMC4237746 DOI: 10.1186/1678-9199-20-48
Source DB: PubMed Journal: J Venom Anim Toxins Incl Trop Dis ISSN: 1678-9180
Figure 1in captivity (A) and its distribution in Turkey (B) represented by the dark area. Red arrow shows location where the specimens were collected (http://www.mapbox.com).
Figure 2Electrophoretic profile of venom. (A) Glycine SDS-PAGE; (B) Tricine SDS-PAGE and (C) MCE results. UM, LM and SP stand for upper marker, lower marker and system peak, respectively.
Figure 3Size exclusion chromatogram of venom. Retention times of protein standards are shown on top. Inset shows the glycine SDS-PAGE profiles of the selected fractions.
Figure 4Reversed-phase chromatogram of venom peptide fraction. The inset shows the glycine SDS-PAGE profile of the selected peaks.
Retention times (RT) and deconvoluted molecular weights (MW) of venom peptides determined by LC-ESI-TOF – 45 molecular masses were identified
| RT (min) | MW (Da) | RT (min) | MW (Da) |
|---|---|---|---|
| 11.50 | 2961, 3000 | 29.14 | 4540, 6810 |
| 12.40 | 3024 | 30.00 | 5376 |
| 12.86 | 2948, 2988, 3183 | 33.32 | 3555, 3576, 3591, 3615, 3630 |
| 15.39 | 3198 | 33.39 | 1067 |
| 15.49 | 3234 | 34.65 | 1155 |
| 20.90 | 3768 | 36.87 | 1287 |
| 21.40 | 3772 | 36.95 | 1331, 1375 |
| 22.56 | 3996 | 37.67 | 1419 |
| 23.37 | 4056, 4092, 4168 | 38.20 | 1463 |
| 23.79 | 3996, 4000 | 39.71 | 1507 |
| 24.19 | 4036 | 43.05 | 1032 |
| 24.86 | 4056 | 64.08 | 1294, 1338 |
| 25.66 | 6780 | 64.15 | 1426 |
| 26.62 | 6805, 6820, 6840, 6855, 6895 | 67.75 | 1082 |
Figure 5Molecular weight distribution of venom peptides.
Figure 6Cytotoxicity assay of venom on MCF-7 breast adenocarcinoma cell line. NC: negative control; Eto: etoposide (60 μM ) positive control; CV: crude venom (200 μg/mL). Error bars represent SD (n = 3). Stars (*, **, ***) denote statistically significant differences at p ≤0.05, p ≤0.01 and p ≤0.001, respectively.
Antimicrobial activity of crude venom determined by agar disk diffusion assay
| Zone of Inhibition (mm) | ||
|---|---|---|
| Crude venom | Antibiotic | |
|
| 27 | 20 (RA5) |
|
| 30 | 37 (TE30) |
|
| 20 | 28 (AMC30) |
|
| 16 | 26 (E15) |
|
| 20 | 21 (E15) |
|
| 23 | 33 (AMC30) |
RA5: 5 μg of rifampin, TE30: 30 μg of tetracycline, AMC30: 30 μg of amoxicillin-clavulanic acid, E15: 15 μg of erythromycin.